Recruiting

Brain Metastasis Development Mechanism in BCBM Patients

This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis

ClinicalTrials.gov IDNCT06330870

PhaseNA

Enrollment30

SponsorSamsung Medical Center

AgeNo minimum reported

SexFEMALE

I'm interested View official listing

Conditions studied

Breast Cancer, Brain Metastasis

About this study

This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis

Interventions

Procedure: WGS/TME evaluation — WGS/TME evaluation with blood and brain metastasis tissue during brain metastasis curative surgery

Primary outcomes

Intracranial disease free survival (Months)

Eligibility information

Inclusion Criteria: * Breast cancer * Brain metastasis curative surgery patient Exclusion Criteria: * Gamma Knife surgery patient

Study locations

Ji-Yeon Kim, Seoul, 06351 South Korea

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.